Skip to main content
. 2012 Oct 5;56(1):100–105. doi: 10.1093/cid/cis859

Figure 1.

Figure 1.

Proportion of patients with wild-type (WT) or precore (PC) and/or basal core promoter (BCP) mutants according to the timing of the flare. Twenty-one patients experienced a flare before week 24, 4 experienced a flare between week 24 and 52, and 25 experienced a flare between week 52 and the end of the study (off-treatment).